These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 10872719)

  • 21. Recent changes in influenza epidemiology and vaccination recommendations.
    Zimmerman RK
    J Fam Pract; 2005 Jan; 54(1 Suppl):S1-8. PubMed ID: 15623391
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterization of an influenza A H5N2 reassortant as a candidate for live-attenuated and inactivated vaccines against highly pathogenic H5N1 viruses with pandemic potential.
    Desheva JA; Lu XH; Rekstin AR; Rudenko LG; Swayne DE; Cox NJ; Katz JM; Klimov AI
    Vaccine; 2006 Nov; 24(47-48):6859-66. PubMed ID: 17050041
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Safety, efficacy and effectiveness of cold-adapted, live, attenuated, trivalent, intranasal influenza vaccine in adults and children.
    Belshe RB; Gruber WC
    Philos Trans R Soc Lond B Biol Sci; 2001 Dec; 356(1416):1947-51. PubMed ID: 11779396
    [TBL] [Abstract][Full Text] [Related]  

  • 24. New developments in influenza vaccine technology: a potential new prevention strategy for employers and managed care organizations.
    Williams JP; Lednar W
    Am J Manag Care; 2002 Apr; 8(5 Suppl):S143-54. PubMed ID: 11999801
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Asthma, influenza, and vaccination.
    Glezen WP
    J Allergy Clin Immunol; 2006 Dec; 118(6):1199-206; quiz 1207-8. PubMed ID: 17157648
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy and safety of 1 and 2 doses of live attenuated influenza vaccine in vaccine-naive children.
    Bracco Neto H; Farhat CK; Tregnaghi MW; Madhi SA; Razmpour A; Palladino G; Small MG; Gruber WC; Forrest BD;
    Pediatr Infect Dis J; 2009 May; 28(5):365-71. PubMed ID: 19395948
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adverse events associated with intranasal influenza vaccine in the United States.
    Vasu N; Ghaffari G; Craig ET; Craig TJ
    Ther Adv Respir Dis; 2008 Aug; 2(4):193-8. PubMed ID: 19124371
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterization of live influenza vaccine donor strain derived from cold-adaptation of X-31 virus.
    Lee KH; Seo SU; Song JM; Lee CM; Kim HA; Seong BL
    Vaccine; 2006 Mar; 24(11):1966-74. PubMed ID: 16343703
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Universal influenza vaccination in the United States: are we ready? Report of a meeting.
    Schwartz B; Hinman A; Abramson J; Strikas RA; Allred N; Uyeki T; Orenstein W
    J Infect Dis; 2006 Nov; 194 Suppl 2():S147-54. PubMed ID: 17163388
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical experience with inactivated, virosomal influenza vaccine.
    de Bruijn IA; Nauta J; Cramer WC; Gerez L; Palache AM
    Vaccine; 2005 Jul; 23 Suppl 1():S39-49. PubMed ID: 16005120
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy and safety of a live attenuated, cold-adapted influenza vaccine, trivalent against culture-confirmed influenza in young children in Asia.
    Tam JS; Capeding MR; Lum LC; Chotpitayasunondh T; Jiang Z; Huang LM; Lee BW; Qian Y; Samakoses R; Lolekha S; Rajamohanan KP; Narayanan SN; Kirubakaran C; Rappaport R; Razmpour A; Gruber WC; Forrest BD;
    Pediatr Infect Dis J; 2007 Jul; 26(7):619-28. PubMed ID: 17596805
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Safety and efficacy of influenza vaccine in children.
    Goldstein LG
    Ann Pharmacother; 2003 Nov; 37(11):1712-5. PubMed ID: 14565808
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vaccination against equine influenza: quid novi?
    Paillot R; Hannant D; Kydd JH; Daly JM
    Vaccine; 2006 May; 24(19):4047-61. PubMed ID: 16545507
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Shedding and immunogenicity of live attenuated influenza vaccine virus in subjects 5-49 years of age.
    Block SL; Yogev R; Hayden FG; Ambrose CS; Zeng W; Walker RE
    Vaccine; 2008 Sep; 26(38):4940-6. PubMed ID: 18662737
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intranasal cold-adapted influenza virus vaccine combined with inactivated influenza virus vaccines: an extra boost for the elderly?
    Targonski PV; Poland GA
    Drugs Aging; 2004; 21(6):349-59. PubMed ID: 15084138
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of an attenuated, live, bivalent, influenza vaccine in children.
    Burech DL; Koranyi KI; Haynes RE
    Ohio State Med J; 1976 Jul; 72(7):385-7. PubMed ID: 934582
    [No Abstract]   [Full Text] [Related]  

  • 37. [Method for the simultaneous immunization against influenza using inactivated and live vaccines].
    Orlov VA; Ermolaeva OM; Malikova EV; Zakharina VN; Konstantinov VK
    Tr Inst Im Pastera; 1982; 59():62-4. PubMed ID: 7187569
    [No Abstract]   [Full Text] [Related]  

  • 38. Comparison of live and inactivated influenza vaccine in high risk children.
    King JC; Gross PA; Denning CR; Gaerlan PF; Wright PF; Quinnan GV
    Vaccine; 1987 Sep; 5(3):234-8. PubMed ID: 3314221
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Immunogenic and reactogenic properties of inactivated influenza vaccine purified and concentrated by gradient centrifugation].
    Malikova EV; Safonova LS; Zueva LP; Znakova GM
    Tr Inst Im Pastera; 1982; 57():122-3. PubMed ID: 6763376
    [No Abstract]   [Full Text] [Related]  

  • 40. Mucosal immunization in perspective.
    Rose MA
    Hum Vaccin Immunother; 2014; 10(7):2115-7. PubMed ID: 25424827
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.